ADVERTISEMENT

Gerhard Mayr appointed to board of GVK Biosciences

in

GVK Biosciences, a contract research organisation, today announced the appointment of Mr Gerhard N. Mayr to its Board of Directors.

Mr. Mayr received a Master's degree in Chemical Engineering from the Swiss Federal Institute of Technology (Zurich, Switzerland) in 1969, and a Master of Business Administration degree from Stanford University in 1972.

He has spent over 32 years with Eli Lilly & Co in various senior management positions and is credited with expanding Lilly's global footprint in several geographies besides creating new business segments across markets. As Executive Vice President during the period 1999 to 2004, Mr. Mayr was responsible for the global pharma operations and sales / marketing at Lilly.

"We are delighted to have Mr. Mayr on our Board. His extensive knowledge of the global research pharma industry will guide our strategic direction and strengthen GVK BIO's position in the global research services space," Mr. D.S.Brar, Chairman, GVK Biosciences, said.

Mr. Mayr is a member of the board of UCB S.A., and a member of the board of Lonza Group Ltd. He is a member of the Apax Healthcare Advisory board, a special advisor to the board of Codexis Inc., and an advisor to Almirall S.A. He is also a member of the board of Project Hope, a member of the board of the Vienna Science-Research and Technology Foundation, and a member of the Circle of patrons of INSEAD. He is past chairman of both the International Executive Committee and the Europe Committee of the Pharmaceutical Research Manufacturers of America (PhRMA).

"I am excited to be associated with GVK BIO as it expands into the global research services space backed by its strong leadership team, scientific talent and established processes" Mr. Mayr said.

NNN

© Copyright 2012 NetIndian. All rights reserved. Republication or redistribution of NetIndian content, including by framing or similar means, is expressly prohibited without the prior written consent of NetIndian Media Corporation. Write to info[AT]netindian[DOT]in for permission to use content. Read detailed Terms of Use.